talazoparib plus enzalutamide
C3441052
Phase 3 small_molecule active
Quick answer
talazoparib plus enzalutamide for Prostate Cancer is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Prostate Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active